Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies

Pharmacology and Therapeutics

Volumn 117, Issue 1, 2008, Pages 30-51

  Kozisek, Megan E ^a   Middlemas, David ^b   Bylund, David B ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b A T STILL UNIVERSITY   (United States)

Author keywords

Antidepressant drugs; BDNF; Depression; Electroconvulsive treatment; Mood disorders; TrkB

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; METHIONINE;

BIPOLAR DISORDER; DEPRESSION; DIET; DRUG MECHANISM; ELECTROCONVULSIVE THERAPY; ENZYME REGULATION; EPILEPSY; INFORMATION PROCESSING; MOOD DISORDER; NERVE CELL NETWORK; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARKINSON DISEASE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; UPREGULATION;

ADULT; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HUMANS; MOOD DISORDERS; RECEPTOR, TRKB;

EID: 36549089541     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.07.001     Document Type: Review

References (209)

1. Ables A.Z., and Baughman O.L. Antidepressants: update on new agents and indications. Am Fam Physician 67 (2003) 547-554
2. Adlard P.A., and Cotman C.W. Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression. Neuroscience 124 (2004) 985-992
3. Adlard P.A., Perreau V.M., Engesser-Cesar C., and Cotman C.W. The timecourse of induction of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus following voluntary exercise. Neurosci Lett 363 (2004) 43-48
4. Alcantara S., Frisen J., del Rio J.A., Soriano E., Barbacid M., and Silos-Santiago I. TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J Neurosci 17 (1997) 3623-3633
5. Alfonso J., Frick L.R., Silberman D.M., Palumbo M.L., Genaro A.M., and Frasch A.C. Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biol Psychiatry 59 (2006) 244-251
6. Altar C.A. Neurotrophins and depression. Trends Pharmacol Sci 20 (1999) 59-61
7. Altar C.A., Boylan C.B., Fritsche M., Jackson C., Hyman C., and Lindsay R.M. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra. Exp Neurol 130 (1994) 31-40
8. Altar C.A., Whitehead R.E., Chen R., Wortwein G., and Madsen T.M. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 54 (2003) 703-709
9. Altieri M., Marini F., Arban R., Vitulli G., and Jansson B.O. Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment. Brain Res 1000 (2004) 148-155
10. Angelucci F., Aloe L., Jimenez-Vasquez P., and Mathe A.A. Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. J ECT 18 (2002) 138-143
11. Avissar S., and Schreiber G. Toward molecular diagnostics of mood disorders in psychiatry. Trends Mol Med 8 (2002) 294-300
12. Aydemir O., Deveci A., and Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 261-265
13. Bamji S.X., Rico B., Kimes N., and Reichardt L.F. BDNF mobilizes synaptic vesicles and enhances synapse formation by disrupting cadherin-beta-catenin interactions. J Cell Biol 174 (2006) 289-299
14. Barde Y.A., Edgar D., and Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1 (1982) 549-553
15. Barnabe-Heider F., and Miller F.D. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J Neurosci 23 (2003) 5149-5160
16. Baron M. Manic-depression genes and the new millennium: poised for discovery. Mol Psychiatry 7 (2002) 342-358
17. Bayer T.A., Schramm M., Feldmann N., Knable M.B., and Falkai P. Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 24 (2000) 881-888
18. Bekinschtein P., Cammarota M., Igaz L.M., Bevilaqua L.R., Izquierdo I., and Medina J.H. Persistence of long-term memory storage requires a late protein synthesis- and. Neuron 53 (2007) 261-277
19. Bengzon J., Kokaia Z., Ernfors P., Kokaia M., Leanza G., Nilsson O.G., et al. Regulation of neurotrophin and trkA, TrkB and trkC tyrosine kinase receptor messenger RNA expression in kindling. Neuroscience 53 (1993) 433-446
20. Berhow M.T., Russell D.S., Terwilliger R.Z., Beitner-Johnson D., Self D.W., Lindsay R.M., et al. Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 68 (1995) 969-979
21. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res Brain Res Rev 28 (1998) 309-369
22. Biffo S., Offenhauser N., Carter B.D., and Barde Y.A. Selective binding and internalisation by truncated receptors restrict the availability of BDNF during development. Development 121 (1995) 2461-2470
23. Binder D.K., Croll S.D., Gall C.M., and Scharfman H.E. BDNF and epilepsy: too much of a good thing?. Trends Neurosci 24 (2001) 47-53
24. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., and Charney D.S. Hippocampal volume reduction in major depression. Am J Psychiatry 157 (2000) 115-118
25. Brown B.S., Payne T., Kim C., Moore G., Krebs P., and Martin W. Chronic response of rat brain norepinephrine and serotonin levels to endurance training. J Appl Physiol 46 (1979) 19-23
26. Bueller J.A., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., and Zubieta J.K. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 59 (2006) 812-815
27. Castren E. Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4 (2004) 58-64
28. Castren E., da Penha B.M., Lindholm D., and Thoenen H. Differential effects of MK-801 on brain-derived neurotrophic factor mRNA levels in different regions of the rat brain. Exp Neurol 122 (1993) 244-252
29. Castren E., Voikar V., and Rantamaki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 7 (2007) 18-21
30. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50 (2001) 260-265
31. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314 (2006) 140-143
32. Cohen S., Levi-Montalcini R., and Hamburger V. A nerve growth-stimulating factor isolated from sarcoma as 37 and 180. Proc Natl Acad Sci U S A 40 (1954) 1014-1018
33. Coppell A.L., Pei Q., and Zetterstrom T.S. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44 (2003) 903-910
34. Coyle J.T., and Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38 (2003) 157-160
35. Cryan J.F., Markou A., and Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23 (2002) 238-245
36. Cryan J.F., O'Leary O.F., Jin S.H., Friedland J.C., Ouyang M., Hirsch B.R., et al. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc Natl Acad Sci U S A 101 (2004) 8186-8191
37. De Foubert G., Carney S.L., Robinson C.S., Destexhe E.J., Tomlinson R., Hicks C.A., et al. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128 (2004) 597-604
38. Dey S., Singh R.H., and Dey P.K. Exercise training: significance of regional alterations in serotonin metabolism of rat brain in relation to antidepressant effect of exercise. Physiol Behav 52 (1992) 1095-1099
39. Dias B.G., Banerjee S.B., Duman R.S., and Vaidya V.A. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45 (2003) 553-563
40. Dimeo F., Bauer M., Varahram I., Proest G., and Halter U. Benefits from aerobic exercise in patients with major depression: a pilot study. Br J Sports Med 35 (2001) 114-117
41. Dishman R.K., Renner K.J., White-Welkley J.E., Burke K.A., and Bunnell B.N. Treadmill exercise training augments brain norepinephrine response to familiar and novel stress. Brain Res Bull 52 (2000) 337-342
42. Duan W., Guo Z., Jiang H., Ware M., Li X.J., and Mattson M.P. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci U S A 100 (2003) 2911-2916
43. Duman R.S. Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 44 (1998) 324-335
44. Duman R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 5 (2004) 11-25
45. Duman R.S. Neurotrophic factors and regulation of mood: role of exercise, diet and metabolism. Neurobiol Aging 26 Suppl 1 (2005) 88-93
46. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59 (2006) 1116-1127
47. Duman R.S., Heninger R.S., and Nestler E.J. Molecular psychiatry: adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity. J Nerv Ment Dis 182 (1994) 692-700
48. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 54 (1997) 597-606
49. Dunn A.L., Reigle T.G., Youngstedt S.D., Armstrong R.B., and Dishman R.K. Brain norepinephrine and metabolites after treadmill training and wheel running in rats. Med Sci Sports Exerc 28 (1996) 204-209
50. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., and Pandey G.N. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77 (2001) 916-928
51. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., and Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60 (2003) 804-815
52. Dwivedi Y., Rizavi H.S., and Pandey G.N. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience 139 (2006) 1017-1029
53. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
54. Eisch A.J., Bolanos C.A., de Wit J., Simonak R.D., Pudiak C.M., Barrot M., et al. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 54 (2003) 994-1005
55. Farmer J., Zhao X., van Praag H., Wodtke K., Gage F.H., and Christie B.R. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 124 (2004) 71-79
56. Ferrer I., Marin C., Rey M.J., Ribalta T., Goutan E., Blanco R., et al. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 58 (1999) 729-739
57. Frey B.N., Andreazza A.C., Cereser K.M., Martins M.R., Valvassori S.S., Reus G.Z., et al. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 79 (2006) 281-286
58. Fujimaki K., Morinobu S., and Duman R.S. Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus. Neuropsychopharmacology 22 (2000) 42-51
59. Fukumoto T., Morinobu S., Okamoto Y., Kagaya A., and Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158 (2001) 100-106
60. Gall C.M. Seizure-induced changes in neurotrophin expression: implications for epilepsy. Exp Neurol 124 (1993) 150-166
61. Garcia C., Chen M.J., Garza A.A., Cotman C.W., and Russo-Neustadt A. The influence of specific noradrenergic and serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity. Neuroscience 119 (2003) 721-732
62. Garza A.A., Ha T.G., Garcia C., Chen M.J., and Russo-Neustadt A.A. Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain. Pharmacol Biochem Behav 77 (2004) 209-220
63. Gervasoni N., Aubry J.M., Bondolfi G., Osiek C., Schwald M., Bertschy G., et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51 (2005) 234-238
64. Goggi J., Pullar I.A., Carney S.L., and Bradford H.F. Signalling pathways involved in the short-term potentiation of dopamine release by BDNF. Brain Res 968 (2003) 156-161
65. Gonul A.S., Akdeniz F., Taneli F., Donat O., Eker C., and Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255 (2005) 381-386
66. Gotz R., Koster R., Winkler C., Raulf F., Lottspeich F., Schartl M., et al. Neurotrophin-6 is a new member of the nerve growth factor family. Nature 372 (1994) 266-269
67. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., and Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 23 (2003) 742-747
68. Haennel R.G., and Lemire F. Physical activity to prevent cardiovascular disease. How much is enough?. Can Fam Physician 48 (2002) 65-71
69. Hall F.S., Drgonova J., Goeb M., and Uhl G.R. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 28 (2003) 1485-1490
70. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23 (2003) 6690-6694
71. Hashimoto K., Shimizu E., and Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 45 (2004) 104-114
72. Hawi Z., Straub R.E., O'Neill A., Kendler K.S., Walsh D., and Gill M. No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families. Psychiatry Res 81 (1998) 111-116
73. Horger B.A., Iyasere C.A., Berhow M.T., Messer C.J., Nestler E.J., and Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 19 (1999) 4110-4122
74. Hoshaw B.A., Malberg J.E., and Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res 1037 (2005) 204-208
75. Hwang J.P., Tsai S.J., Hong C.J., Yang C.H., Lirng J.F., and Yang Y.M. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 27 (2006) 1834-1837
76. Isackson P.J., Huntsman M.M., Murray K.D., and Gall C.M. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron 6 (1991) 937-948
77. Ivy A.S., Rodriguez F.G., Garcia C., Chen M.J., and Russo-Neustadt A.A. Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav 75 (2003) 81-88
78. Jacobsen J.P., and Mork A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res 1024 (2004) 183-192
79. Jeste D.V., Harris M.J., Krull A., Kuck J., McAdams L.A., and Heaton R. Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. Am J Psychiatry 152 (1995) 722-730
80. Kang H., Welcher A.A., Shelton D., and Schuman E.M. Neurotrophins and time: different roles for TrkB signaling in hippocampal long-term potentiation. Neuron 19 (1997) 653-664
81. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., and Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109 (2002) 143-148
82. Karege F., Schwald M., and Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328 (2002) 261-264
83. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M., and Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57 (2005) 1068-1072
84. Kaufman J., Yang B.Z., Douglas-Palumberi H., Grasso D., Lipschitz D., Houshyar S., et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 59 (2006) 673-680
85. Khundakar A.A., and Zetterstrom T.S.C. Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation. Brain Res 1106 (2006) 12-20
86. Kim J.J., and Yoon K.S. Stress: metaplastic effects in the hippocampus. Trends Neurosci 21 (1998) 505-509
87. Kleim J.A., Chan S., Pringle E., Schallert K., Procaccio V., Jimenez R., et al. BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci 9 (2006) 735-737
88. Klein R. Role of neurotrophins in mouse neuronal development. FASEB J 8 (1994) 738-744
89. Klein R., Smeyne R.J., Wurst W., Long L.K., Auerbach B.A., Joyner A.L., et al. Targeted disruption of the TrkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 75 (1993) 113-122
90. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P.J., Markou A., et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27 (2004) 739-749
91. Kornblum H.I., Sankar R., Shin D.H., Wasterlain C.G., and Gall C.M. Induction of brain derived neurotrophic factor mRNA by seizures in neonatal and juvenile rat brain. Brain Res Mol Brain Res 44 (1997) 219-228
92. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., and Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci U S A 92 (1995) 8856-8860
93. Kuroda Y., and McEwen B.S. Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein-43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus. Brain Res Mol Brain Res 59 (1998) 35-39
94. Lee A.L., Ogle W.O., and Sapolsky R.M. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord 4 (2002) 117-128
95. Legutko B., Szewczyk B., Pomierny-Chamiolo L., Nowak G., and Pilc A. Effect of MPEP treatment on brain-derived neurotrophic factor gene expression. Pharmacol Rep 58 (2006) 427-430
96. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341 (1989) 149-152
97. Li B., Suemaru K., Cui R., and Araki H. Repeated electroconvulsive stimuli have long-lasting effects on hippocampal BDNF and decrease immobility time in the rat forced swim test. Life Sci 80 (2007) 1539-1543
98. Lindefors N., Brodin E., and Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and TrkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience 65 (1995) 661-670
99. Lindsay R.M., Wiegand S.J., Altar C.A., and DiStefano P.S. Neurotrophic factors: from molecule to man. Trends Neurosci 17 (1994) 182-190
100. Lindvall O., Kokaia Z., Bengzon J., Elmer E., and Kokaia M. Neurotrophins and brain insults. Trends Neurosci 17 (1994) 490-496
101. Liu Y., Encinas M., Comella J.X., Aldea M., and Gallego C. Basic helix-loop-helix proteins bind to TrkB and p21(Cip1) promoters linking differentiation and cell cycle arrest in neuroblastoma cells. Mol Cell Biol 24 (2004) 2662-2672
102. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A 96 (1999) 15239-15244
103. MacQueen G.M., Ramakrishnan K., Croll S.D., Siuciak J.A., Yu G., Young L.T., et al. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 115 (2001) 1145-1153
104. Maisonpierre P.C., Le Beau M.M., Espinosa R., Ip I.I.I., Belluscio N.Y., de la Monte L., et al. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 10 (1991) 558-568
105. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20 (2000) 9104-9110
106. Mamounas L.A., Blue M.E., Siuciak J.A., and Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 15 (1995) 7929-7939
107. Mamounas L.A., Altar C.A., Blue M.E., Kaplan D.R., Tessarollo L., and Lyons W.E. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20 (2000) 771-782
108. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat Med 7 (2001) 541-547
109. Marano C.M., Phatak P., Vemulapalli U.R., Sasan A., Nalbandyan M.R., Ramanujam S., et al. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. J Clin Psychiatry 68 (2007) 512-517
110. Martin-Iverson M.T., Todd K.G., and Altar C.A. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J Neurosci 14 (1994) 1262-1270
111. Martinez-Turrillas R., Del R.J., and Frechilla D. Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment. Neuropharmacology 49 (2005) 1178-1188
112. Mathers C., and Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3 (2006) e442
113. Mattson M.P. Energy intake, meal frequency, and health: a neurobiological perspective. Annu Rev Nutr 25 (2005) 237-260
114. Mattson M.P., Maudsley S., and Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 27 (2004) 589-594
115. McEwen B.S. Stress and the aging hippocampus. Front Neuroendocrinol 20 (1999) 49-70
116. Meredith G.E., Callen S., and Scheuer D.A. Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Res 949 (2002) 218-227
117. Middlemas D.S., Lindberg R.A., and Hunter T. TrkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol Cell Biol 11 (1991) 143-153
118. Minichiello L., Korte M., Wolfer D., Kuhn R., Unsicker K., Cestari V., et al. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24 (1999) 401-414
119. Miro X., Perez-Torres S., Artigas F., Puigdomenech P., Palacios J.M., and Mengod G. Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology 43 (2002) 1148-1157
120. Mogi M., Togari A., Kondo T., Mizuno Y., Komure O., Kuno S., et al. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease. Neurosci Lett 270 (1999) 45-48
121. Molteni R., Ying Z., and Gomez-Pinilla F. Differential effects of acute and chronic exercise on plasticity-related genes in the rat hippocampus revealed by microarray. Eur J Neurosci 16 (2002) 1107-1116
122. Momose Y., Murata M., Kobayashi K., Tachikawa M., Nakabayashi Y., Kanazawa I., et al. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann Neurol 51 (2002) 133-136
123. Monteggia L.M., Barrot M., Powell C.M., Berton O., Galanis V., Gemelli T., et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci U S A 101 (2004) 10827-10832
124. Monteleone P., Tortorella A., Martiadis V., Serritella C., Fuschino A., and Maj M. Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosom Med 66 (2004) 744-748
125. Muglia P., Vicente A.M., Verga M., King N., Macciardi F., and Kennedy J.L. Association between the BDNF gene and schizophrenia. Mol Psychiatry 8 (2003) 146-147
126. Nair A., and Vaidya V.A. Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood?. J Biosci 31 (2006) 423-434
127. Nair A., Vadodaria K.C., Banerjee S.B., Benekareddy M., Dias B.G., Duman R.S., et al. Stressor-Specific Regulation of Distinct Brain-Derived Neurotrophic Factor Transcripts and Cyclic AMP Response Element-Binding Protein Expression in the Postnatal and Adult Rat Hippocampus. Neuropsychopharmacology (2006)
128. Nakagawa T., Tsuchida A., Itakura Y., Nonomura T., Ono M., Hirota F., et al. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 49 (2000) 436-444
129. Nakazato M., Hashimoto K., Shimizu E., Kumakiri C., Koizumi H., Okamura N., et al. Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol Psychiatry 54 (2003) 485-490
130. Neeper S.A., Gomez-Pinilla F., Choi J., and Cotman C.W. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 726 (1996) 49-56
131. Nestler E.J., and Carlezon Jr. W.A. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59 (2006) 1151-1159
132. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
133. Neves-Pereira M., Mundo E., Muglia P., King N., Macciardi F., and Kennedy J.L. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71 (2002) 651-655
134. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10 (2005) 208-212
135. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and TrkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15 (1995) 7539-7547
136. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16 (1996) 2365-2372
137. Nilsson A.S., Fainzilber M., Falck P., and Ibanez C.F. Neurotrophin-7: a novel member of the neurotrophin family from the zebrafish. FEBS Lett 424 (1998) 285-290
138. Nitta A., Ohmiya M., Sometani A., Itoh M., Nomoto H., Furukawa Y., et al. Brain-derived neurotrophic factor prevents neuronal cell death induced by corticosterone. J Neurosci Res 57 (1999) 227-235
139. Okamoto H., Shino Y., Hashimoto K., Kumakiri C., Shimizu E., Shirasawa H., et al. Dynamic changes in AP-1 transcription factor DNA binding activity in rat brain following administration of antidepressant amitriptyline and brain-derived neurotrophic factor. Neuropharmacology 45 (2003) 251-259
140. Olfson M., Marcus S., Sackeim H.A., Thompson J., and Pincus H.A. Use of ECT for the Inpatient Treatment of Recurrent Major Depression. Am J Psychiatry 155 (1998) 22-29
141. Oliff H.S., Berchtold N.C., Isackson P., and Cotman C.W. Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Mol Brain Res 61 (1998) 147-153
142. Page M.E., Detke M.J., Dalvi A., Kirby L.G., and Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 147 (1999) 162-167
143. Pan W., Banks W.A., Fasold M.B., Bluth J., and Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37 (1998) 1553-1561
144. Pang P.T., Teng H.K., Zaitsev E., Woo N.T., Sakata K., Zhen S., et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306 (2004) 487-491
145. Patterson S.L., Abel T., Deuel T.A., Martin K.C., Rose J.C., and Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16 (1996) 1137-1145
146. Pencea V., Bingaman K.D., Wiegand S.J., and Luskin M.B. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci 21 (2001) 6706-6717
147. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24 (2004) 10099-10102
148. Pinon L.G., Minichiello L., Klein R., and Davies A.M. Timing of neuronal death in trkA, TrkB and trkC mutant embryos reveals developmental changes in sensory neuron dependence on Trk signalling. Development 122 (1996) 3255-3261
149. Pinto B.M., Clark M.M., Maruyama N.C., and Feder S.I. Psychological and fitness changes associated with exercise participation among women with breast cancer. Psychooncology 12 (2003) 118-126
150. Poduslo J.F., and Curran G.L. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res 36 (1996) 280-286
151. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
152. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47 (1978) 379-391
153. Proschel M., Saunders A., Roses A.D., and Muller C.R. Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF). Hum Mol Genet 1 (1992) 353
154. Radka S.F., Holst P.A., Fritsche M., and Altar C.A. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 709 (1996) 122-301
155. Rasmusson A.M., Shi L., and Duman R. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology 27 (2002) 133-142
156. Roceri M., Hendriks W., Racagni G., Ellenbroek B.A., and Riva M.A. Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Mol Psychiatry 7 (2002) 609-616
157. Russo-Neustadt A., Beard R.C., and Cotman C.W. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21 (1999) 679-682
158. Russo-Neustadt A.A., Beard R.C., Huang Y.M., and Cotman C.W. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 101 (2000) 305-312
159. Russo-Neustadt A., Ha T., Ramirez R., and Kesslak J.P. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res 120 (2001) 87-95
160. Russo-Neustadt A.A., Alejandre H., Garcia C., Ivy A.S., and Chen M.J. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 29 (2004) 2189-2199
161. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23 (2003) 349-357
162. Sairanen M., Lucas G., Ernfors P., Castren M., and Castren E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 25 (2005) 1089-1094
163. Sairanen M., O'Leary O.F., Knuuttila J.E., and Castren E. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience 144 (2007) 368-374
164. Samorajski T., Rolsten C., Przykorska A., and Davis C.M. Voluntary wheel running exercise and monoamine levels in brain, heart and adrenal glands of aging mice. Exp Gerontol 22 (1987) 421-431
165. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
166. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57 (2000) 925-935
167. Sasaki T., Dai X.Y., Kuwata S., Fukuda R., Kunugi H., Hattori M., et al. Brain-derived neurotrophic factor gene and schizophrenia in Japanese subjects. Am J Med Genet 74 (1997) 443-444
168. Schinder A.F., and Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci 23 (2000) 639-645
169. Schmidt-Kastner R., Wetmore C., and Olson L. Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular level suggests multiple roles in hippocampus, striatum and cortex. Neuroscience 74 (1996) 161-183
170. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93 (1996) 3908-3913
171. Sheline Y.I., Sanghavi M., Mintun M.A., and Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19 (1999) 5034-5043
172. Sheline Y.I., Gado M.H., and Kraemer H.C. Untreated depression and hippocampal volume loss. Am J Psychiatry 160 (2003) 1516-1518
173. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54 (2003) 70-75
174. Shimizu E., Hashimoto K., and Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet 126 (2004) 122-123
175. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22 (2002) 3251-3261
176. Singh N.A., Clements K.M., and Singh M.A. The efficacy of exercise as a long-term antidepressant in elderly subjects: a randomized, controlled trial. J Gerontol A Biol Sci Med Sci 56 (2001) M497-M504
177. Siuciak J.A., Boylan C., Fritsche M., Altar C.A., and Lindsay R.M. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res 710 (1996) 11-20
178. Siuciak J.A., Lewis D.R., Wiegand S.J., and Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56 (1997) 131-137
179. Siuciak J.A., Clark M.S., Rind H.B., Whittemore S.R., and Russo A.F. BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain. J Neurosci Res 52 (1998) 149-158
180. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15 (1995) 1768-1777
181. Smith M.A., Zhang L.X., Lyons W.E., and Mamounas L.A. Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. Neuroreport 8 (1997) 1829-1834
182. Soppet D., Escandon E., Maragos J., Middlemas D.S., Reid S.W., Blair J., et al. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the TrkB tyrosine kinase receptor. Cell 65 (1991) 895-903
183. Squinto S.P., Stitt T.N., Aldrich T.H., Davis S., Bianco S.M., Radziejewski C., et al. TrkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65 (1991) 885-893
184. Strauss J., Barr C.L., George C.J., Devlin B., Vetro A., Kiss E., et al. Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample. Mol Psychiatry 10 (2005) 861-867
185. Szeszko P.R., Lipsky R., Mentschel C., Robinson D., Gunduz-Bruce H., Sevy S., et al. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 10 (2005) 631-636
186. Thoenen H. Neurotrophins and neuronal plasticity. Science 270 (1995) 593-598
187. Torregrossa M.M., Isgor C., Folk J.E., Rice K.C., Watson S.J., and Woods J.H. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats. Neuropsychopharmacology 29 (2004) 649-659
188. Torregrossa M.M., Folk J.E., Rice K.C., Watson S.J., and Woods J.H. Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats. Psychopharmacology (Berl) 183 (2005) 31-40
189. Tsai S.J. Increased central brain-derived neurotrophic factor activity could be a risk factor for substance abuse: Implications for treatment. Med Hypotheses 68 (2007) 410-414
190. Tsuchida A., Nonomura T., Ono-Kishino M., Nakagawa T., Taiji M., and Noguchi H. Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice. Int J Obes Relat Metab Disord 25 (2001) 1286-1293
191. Tsuchida A., Nonomura T., Nakagawa T., Itakura Y., Ono-Kishino M., Yamanaka M., et al. Brain-derived neurotrophic factor ameliorates lipid metabolism in diabetic mice. Diabetes Obes Metab 4 (2002) 262-269
192. Tyler W.J., and Pozzo-Miller L.D. BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. J Neurosci 21 (2001) 4249-4258
193. Vaidya V.A., and Duman R.S. Depresssion-emerging insights from neurobiology. Br Med Bull 57 (2001) 61-79
194. Vaidya V.A., Marek G.J., Aghajanian G.K., and Duman R.S. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 17 (1997) 2785-2795
195. Vaidya V.A., Siuciak J.A., Du F., and Duman R.S. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 89 (1999) 157-166
196. Ventimiglia R., Mather P.E., Jones B.E., and Lindsay R.M. The NeurotroDhins BDNF, NT-3 and NT-4/5 Promote Survival and Morphological and Biochemical Differentiation of Striatal Neurons In Vitro. Eur J Neurosci 7 (1995) 213-222
197. Ventriglia M., Bocchio C.L., Benussi L., Binetti G., Zanetti O., Riva M.A., et al. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 7 (2002) 136-137
198. Virgos C., Martorell L., Valero J., Figuera L., Civeira F., Joven J., et al. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr Res 49 (2001) 65-71
199. Wahlund B., and von Rosen D. ECT of major depressed patients in relation to biological and clinical variables: a brief overview. Neuropsychopharmacology 28 Suppl 1 (2003) S21-S26
200. Wannamethee G., and Shaper A.G. Physical activity and stroke in British middle aged men. BMJ 304 (1992) 597-601
201. Wassink T.H., Nelson J.J., Crowe R.R., and Andreasen N.C. Heritability of BDNF alleles and their effect on brain morphology in schizophrenia. Am J Med Genet 88 (1999) 724-728
202. Wilkie M.J., Smith D., Reid I.C., Day R.K., Matthews K., Wolf C.R., et al. A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression. Pharmacogenet Genom 17 (2007) 207-215
203. Wong M.L., and Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci 2 (2001) 343-351
204. Xu H., Steven R.J., and Li X.M. Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 28 (2003) 53-62
205. Yamamoto H., and Gurney M.E. Human platelets contain brain-derived neurotrophic factor. J Neurosci 10 (1990) 3469-3478
206. Yuan J., and Yankner B.A. Apoptosis in the nervous system. Nature 407 (2000) 802-809
207. Zetterstrom T.S., Pei Q., and Grahame-Smith D.G. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res Mol Brain Res 57 (1998) 106-110
208. Zetterstrom T.S., Pei Q., Madhav T.R., Coppell A.L., Lewis L., and Grahame-Smith D.G. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 38 (1999) 1063-1073
209. Zigova T., Pencea V., Wiegand S.J., and Luskin M.B. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Mol Cell Neurosci 11 (1998) 234-245